Unexpectedly, however, in the present study, we show that cisplatin treatment does not significantly reduce kidney DAO activity, indicating that d-serine accumulation in the kidney diseases occurs also through a mechanism independent of DAO. This evidence concerns the gene DAO and kidney disorder.